Microarray Gene Chip Scanner Market
Number of pages: 100 | Report Format: PDF | Published date: March 06, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 850 million |
|
Revenue Forecast in 2031 |
US$ 1,390 million |
|
CAGR |
6.8% |
|
Base Year For Estimation |
2022 |
|
Forecast Period |
2023-2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Type, Application, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global microarray gene chip scanner market was valued at US$ 850 million in 2022 and is expected to register a revenue CAGR of 6.8% to reach US$ 1,390 million by 2031.
Microarray Gene Chip Scanner Market Fundamentals
A microarray gene chip scanner is a device used to scan and read the results of microarray experiments. Microarrays are an effective tool for genetic research that enables researchers to simultaneously examine the expression levels of thousands of genes. They are made of tiny glass or silicon chips with thousands of DNA or RNA probes printed on them, each corresponding to a different gene or gene fragment. A microarray chip is hybridized with labeled cDNA or RNA samples, which bind to the chip’s relevant probes to assess the gene expression levels on the chip. The microarray gene chip scanner identifies and measures the strength of fluorescent signals generated by the bound samples. These scanners use high-resolution imaging technology to identify and measure the fluorescent signals produced by hybridized samples.
The scanners can detect signals from multiple fluorescent dyes, allowing for the simultaneous analysis of multiple samples on a single microarray chip. Microarray gene chip scanners are available in different formats, ranging from compact benchtop instruments to high-throughput robotic systems. They are used in various research applications, including gene expression profiling, genotyping, and molecular diagnostics. Overall, microarray gene chip scanners are a critical component of microarray experiments, enabling the analysis of large amounts of genetic data quickly and accurately. The technology continues to evolve, with ongoing improvements in sensitivity, resolution, and throughput, making it an important tool for genetic research and personalized medicine.
[68565]
Microarray Gene Chip Scanner Market Dynamics
The demand for personalized medicine is one of the factors driving the global microarray gene chip scanner market. These scanners assist in locating genetic variances in people, which can be utilized to create specialized treatments. Their use in research and diagnostic applications has expanded due to the creation of new, sophisticated, and sensitive microarray gene chip scanners. The rising incidence of chronic diseases, such as cancer, cardiovascular diseases, and neurological disorders, has led to increased research activities that utilize microarray gene chip scanners for biomarker discovery and drug development. Many governments are investing in research and development activities related to genetic analysis and personalized medicine. This has increased the availability of funds to purchase microarray gene chip scanners and other related equipment. The increasing awareness and adoption of precision medicine, which aims at providing personalized treatments based on a patient’s genetic makeup, has led to an increase in the usage of microarray gene chip scanners.
Research collaborations and partnerships between academic and research institutions, government agencies, and biotechnology and pharmaceutical companies have contributed to the revenue growth of the microarray gene chip scanner market by providing access to advanced technologies and research facilities. Overall, the microarray gene chip scanner market is driven by the growing demand for personalized medicine, technological advancements, and increasing research in genetic analysis and personalized medicine.
However, the cost of microarray gene chip scanners and related equipment is relatively high, which limits their adoption by smaller research organizations and academic institutions. The complex nature of microarray gene chip scanners and their applications can limit their adoption by researchers and clinicians who may need more training or understanding of the technology. Alternative technologies, such as next-generation sequencing (NGS), have emerged as viable alternatives to microarray gene chip scanners for genetic analysis, which can limit the revenue growth of the microarray gene chip scanner market. The regulatory landscape for genetic analysis and personalized medicine constantly evolves, creating uncertainties and challenges for companies operating in the microarray gene chip scanner market.
Microarray Gene Chip Scanner Market Ecosystem
The global microarray gene chip scanner market has been analyzed from three perspectives: type, application, and region.
Microarray Gene Chip Scanner Market by Type
[85655]
Based on type, the global microarray gene chip scanner market has been segmented into CCD system biochip scanners and laser confocal biochip scanners.
The CCD system biochip scanners segment accounts for the largest revenue share in the global microarray gene chip scanner market. These scanners scan the microarray chip using a charge-coupled device (CCD) camera, which detects the fluorescent signals emitted by the probes on the chip. It converts them into digital data that a computer can analyze. CCD system biochip scanners are relatively simple and affordable, making them popular among researchers. Technological advancements, increasing research funding, and the rising prevalence of genetic diseases are all expected to contribute to this growth.
Laser confocal biochip scanners, on the other hand, use a laser to excite the fluorescent probes on the chip and then detect the emitted signals using a confocal microscope. This technique allows for higher resolution and sensitivity than CCD system scanners but comes at a higher cost. The laser confocal biochip scanners segment is projected to continue growing in the coming years as the demand for genomic and proteomic research continues to increase.
Microarray Gene Chip Scanner Market by Application
Based on application, the global microarray gene chip scanner market has been segmented into drug screening, tumor detection, and personalized medicine.
The drug screening segment accounts for the largest revenue share in the global microarray gene chip scanner market. Drug screening is one of the key applications of microarray gene chip scanners. Researchers can use these scanners to study the effects of drugs on gene expression, which can help identify potential drug targets and lead to the development of new drugs. Tumor detection is another important application of microarray gene chip scanners. Researchers can identify specific genes associated with different cancer types by analyzing gene expression patterns in cancer cells. This information can then be used to develop new diagnostic tests and treatments. Personalized medicine is a rapidly growing field that uses genomic information to tailor medical treatments to individual patients. Microarray gene chip scanners are an important tool in personalized medicine. They allow researchers to analyze large amounts of genetic information and identify genetic variations that may impact a patient’s response to different treatments.
Microarray Gene Chip Scanner Market by Region
Based on region, the global microarray gene chip scanner market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
North America accounts for the largest revenue share in the global microarray gene chip scanner market. The demand for these devices is increasing due to the growing need for high-throughput drug discovery and development. In addition, the increasing prevalence of chronic diseases is driving the demand for gene expression analysis. As a result, companies are investing in research and development to improve the performance of microarray gene chip scanners.
The microarray gene chip scanner market is projected to register significant revenue growth in Asia Pacific during the forecast period due to the increasing focus on personalized medicine and the rising incidence of chronic diseases, such as cancer, cardiovascular diseases, and neurological disorders. The increasing demand for efficient and accurate diagnostic tools also contributes to market revenue growth. China, Japan, India, and South Korea are the major countries driving the microarray gene chip scanner market revenue growth in Asia Pacific. In China, the market is primarily driven by the increasing adoption of microarray gene chip scanners in research and development activities. The rising demand for personalized medicine and the increasing focus on genomic research drive Japan’s market. In India and South Korea, the market is primarily driven by the rising prevalence of chronic diseases and the need for accurate and efficient diagnostic tools.
Microarray Gene Chip Scanner Market Competitive Landscape
The prominent players operating in the global microarray gene chip scanner market are:
Microarray Gene Chip Scanner Market Strategic Developments
The microarray gene chip scanner market has had a growing consolidation trend in recent years, with multiple mergers and acquisitions among the major competitors.
The global microarray gene chip scanner market is expected to grow at a revenue CAGR of 6.8% during the forecast period.
Thermo Fisher Scientific Inc., Agilent Technologies, Applied Precision, Beijing Novogene, and Pilot Gene Technology are among the key players in the global microarray gene chip scanner market.
The CCD systems biochip scanners segment dominates the global microarray gene chip scanner market.
Asia Pacific is expected to observe the highest revenue growth in the global microarray gene chip scanner market during the forecast period.
The global microarray gene chip scanner market was valued at US$ 850 million in 2022.
*Insights on financial performance are subject to the availability of information in the public domain